Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon D Emery

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
International Journal of Health Policy and Management|November 24, 2021
How to Realize the Benefits of Point-of-Care Testing at the General Practice: A Comparison of Four High-Income CountriesDeon Lingervelder, Hendrik Koffijberg, Jon D Emery, et al.
BMJ (Clinical Research Ed.)|July 6, 2012
Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trialFiona M Walter, Helen C Morris, Elka Humphrys, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2013
The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic modelEdward C F Wilson, Jon D Emery, Ann Louise Kinmonth, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Factors Explaining Socio-Economic Inequalities in Survival from Colon Cancer: A Causal Mediation AnalysisNina Afshar, S Ghazaleh Dashti, Luc Te Marvelde, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 8, 2018
Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in AustraliaJie-Bin Lew, D James B St John, Finlay A Macrae, et al.
BMC Cancer|June 16, 2019
Evaluating diagnostic strategies for early detection of cancer: the CanTest frameworkFiona M Walter, Matthew J Thompson, Ian Wellwood, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 29, 2020
Breast Cancer Chemoprevention: Use and Views of Australian Women and Their CliniciansCourtney Macdonald, Christobel M Saunders, Louise A Keogh, et al.
International Journal of Cancer|February 15, 2018
Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in AustraliaJie-Bin Lew, D James B St John, Finlay A Macrae, et al.
Eclinicalmedicine|December 14, 2023
SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancerMichael Jefford, Jon D Emery, Andrew James Martin, et al.
Trials|March 20, 2026
Testing interventions to increase participation in the Australian National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trialJennifer G McIntosh, Belinda Goodwin, Driss Ait Ouakrim, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Health Policy and Management|November 24, 2021
How to Realize the Benefits of Point-of-Care Testing at the General Practice: A Comparison of Four High-Income CountriesDeon Lingervelder, Hendrik Koffijberg, Jon D Emery, et al.
BMJ (Clinical Research Ed.)|July 6, 2012
Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trialFiona M Walter, Helen C Morris, Elka Humphrys, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2013
The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic modelEdward C F Wilson, Jon D Emery, Ann Louise Kinmonth, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Factors Explaining Socio-Economic Inequalities in Survival from Colon Cancer: A Causal Mediation AnalysisNina Afshar, S Ghazaleh Dashti, Luc Te Marvelde, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 8, 2018
Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in AustraliaJie-Bin Lew, D James B St John, Finlay A Macrae, et al.
BMC Cancer|June 16, 2019
Evaluating diagnostic strategies for early detection of cancer: the CanTest frameworkFiona M Walter, Matthew J Thompson, Ian Wellwood, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 29, 2020
Breast Cancer Chemoprevention: Use and Views of Australian Women and Their CliniciansCourtney Macdonald, Christobel M Saunders, Louise A Keogh, et al.
International Journal of Cancer|February 15, 2018
Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in AustraliaJie-Bin Lew, D James B St John, Finlay A Macrae, et al.
Eclinicalmedicine|December 14, 2023
SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancerMichael Jefford, Jon D Emery, Andrew James Martin, et al.
Trials|March 20, 2026
Testing interventions to increase participation in the Australian National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trialJennifer G McIntosh, Belinda Goodwin, Driss Ait Ouakrim, et al.
Pageof 14